AKAdam O. Kadlec

Adam O. Kadlec

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adam O. Kadlec has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Nonlinear logistic regression model for outcomes after endourologic procedures: a novel predictor

    by Adam O. Kadlec, Samuel Ohlander, James Hotaling, Jessica Hannick, Craig Niederberger, Thomas M. Turk

    The purpose of this study was to design a thorough and practical nonlinear logistic regression model that can be used for outcome prediction after various forms of endourologic intervention. Input variables and outcome data from 382 renal units endourologically treated at a single institution were used to build and cross-validate an independently designed nonlinear logistic regression model. Model outcomes were stone-free status and need for a secondary procedure. The model predicted stone-free status with sensitivity 75.3 % and specificity 60.4 %, yielding a positive predictive value (PPV) of 75.3 % and negative predictive value (NPV) of 60.4 %, with classification accuracy of 69.6 %. Receiver operating characteristic area under the curve (ROC AUC) was 0.749. The model predicted the need for a secondary procedure with sensitivity 30 % and specificity 98.3 %, yielding a PPV of 60 % and NPV of 94.2 %. ROC AUC was 0.863. The model had equivalent predictive value to a traditional logistic regression model for the secondary procedure outcome. This study is proof-of-concept that a nonlinear regression model adequately predicts key clinical outcomes after shockwave lithotripsy, ureteroscopic lithotripsy, and percutaneous nephrolithotomy. This model holds promise for further optimization via dataset expansion, preferably with multi-institutional data, and could be developed into a predictive nomogram in the future.


    • 1 November 2013
      • Vol. 98  (11) , 20-1

    Choosing a physician in the Yelp era.

    by Chandy Ellimoottil, Adam O Kadlec, Ahmer Farooq, Marcus L Quek


  • Contemporary Volume–Outcome Relationships for Percutaneous Nephrolithotomy: Results from the Nationwide Inpatient Sample

    by Adam O. Kadlec, Chandy Ellimoottil, Rong Guo, Quoc-Dien Trinh, Maxine Sun, Thomas M. Turk

    Introduction/Objective: We sought to examine the contemporary relationship between case volume and outcome for percutaneous nephrolithotomy (PCNL) using a publicly available administrative database. Methods: A weighted sample of 7785 patients was obtained from the 2010 Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS). ICD-9-CM diagnostic codes were used to identify patients with urolithiasis (592.0, 592.1, and 592.9) who underwent percutaneous nephrostomy with fragmentation (5504). Charlson Comorbidity Indices (CCI) were calculated based on diagnostic codes for all patients. Hospital case volume was quartile classified and we then compared key outcomes (the complication rate, transfusion rate, length of stay [LOS], and in-hospital mortality rate) by volume quartile. We then performed multivariate analysis to examine the effect of CCI, annual volume, and age on key outcomes. Results: The overall complication rate was 17% in the weighted sample. In univariate analysis, statistically significant variation in the complication rate, CCI, transfusion rate, and in-hospital mortality was noted with regard to the hospital volume. The complication rate and transfusion rates varied by case volume, but in a nonlinear fashion, wherein rates were highest at the lowest and highest volume centers. CCI was strongly predictive (pp=0.042) of LOS in the multivariate analysis. Conclusion: Annual case volume of the treating center was associated with shorter LOS after PCNL, but case volume was not independently predictive of complication or transfusion in multivariate analysis. CCI was a strong independent predictor of complication and LOS.


  • Five-Year Experience with Metallic Stents for Chronic Ureteral Obstruction

    by Adam O. Kadlec, Chandy S. Ellimoottil, Kristin A. Greco, Thomas M. Turk

    We present 5 years of outcome data on metallic ureteral stents in a cohort of patients treated for chronic ureteral obstruction. We retrospectively identified and analyzed the records of all patients in whom a Resonance® Metallic Ureteral Stent was placed between early 2007 and late 2011 at our institution. We performed a descriptive analysis of key outcomes, including the failure and death rates, and stenting duration, defined as the time from initial stent placement to last stent failure or patient death. We also performed a secondary comparative analysis of patients with a benign vs malignant etiology of obstruction. A total of 139 metallic stents were placed in 47 patients, including 27 (57%) with malignant and 20 (43%) with a benign etiology. Of the patients 15 (32%) had bilateral obstruction. Maximum followup was 59 months (mean 20, median 13, IQR 4-31). Stent failure occurred in 13 patients (28%), including 4 in the benign and 9 in the malignant group (p = 0.35). The median duration of stenting for benign and malignant obstruction was 22 (IQR 9-39) vs 7 months (IQR 3-25) (p = 0.106). Stenting duration was equivalent when controlling for the higher death rate in the malignant group. Resonance metallic stents are an adequate management strategy for benign and malignant ureteral obstruction. A subset of patients in each group continued to do well at more than a 3-year overall duration of stenting. Failure rates were similar for benign and malignant etiologies.


  • Update on the Evaluation of Repeated Stone Formers

    by Adam O. Kadlec, Thomas M. Turk

    Office management of stone disease is an important component of a urologist’s practice. Evaluation should include analysis of stone composition, 24-hour urine studies, identification of modifiable risk factors, and targeted dietary, lifestyle, and/or medical therapy. A sizeable portion of investigated etiologies and risk factors for stone disease have centered on the complex interplay between obesity, diabetes, and other disease states that comprise the metabolic syndrome. Alternatives to traditional preventive therapy, such as probiotics and various fruit juices, are still being studied but may prove useful adjuncts to traditional preventive therapy, where the mainstays remain increased fluid intake, dietary modification, and pharmacologic therapy. Future studies on preventive therapy of urolithiasis are likely to focus on strategies to increase compliance, cost-effectiveness, and systems-based implementation.


  • Bilateral urinary calculi with discordant stone composition

    by Adam O. Kadlec, Zachary C. Fridirici, Alex M. Acosta-Miranda, Thomas H. Will, Kyoko Sakamoto, Thomas M. T. Turk

    To describe a cohort of bilateral stone formers with significantly different compositions between renal units. Patients treated for bilateral nephrolithiasis over a 4-year period (2007–2010) were identified. Stones were categorized by dominant (≥50 %) mineralogical component. Patients with significant compositional differences between renal units (discordant stone formers) were compared to patients with a similar stone type in each kidney. Fifteen of the 59 bilateral stone formers (25.4 %) were discordant stone formers with significant differences in stone composition between renal units. Forty-four of the 59 patients (74.6 %) had the same stone composition on each side. Thirty percent of discordant stones had calcium phosphate as the dominant stone component. Discordant stone formers were younger, had better renal function, and tended to have a larger stone burden (p < 0.05). A significant minority of bilateral stone formers form a different type of stone in each kidney. Local or micro-environmental etiologies may explain this phenomenon and may also account for failure of preventive therapy in some patients.


  • Mini-Percutaneous Nephrolithotomy with Ureteral Access Sheath in a Transplanted Kidney: Case Report and Literature Review

    by Adam O. Kadlec, Michael J. Ross, John E. Milner

    This is the case of a 69-year-old woman with a history of right iliac fossa living-related kidney transplant that developed acute renal failure due to an obstructing stone in the proximal transplant ureter. She was successfully treated with mini-percutaneous nephrolithotomy wherein a 14-Fr tract was created with serial dilation and a 14-Fr ureteral access sheath was used for access. A flexible ureteroscope with holmium laser and a helical wire basket were used to fragment and extract the stone, respectively. A 10-Fr nephrostomy tube was left for postoperative drainage. There are only a few published reports of mini-percutaneous nephrolithotomy in transplant kidneys, but those reports suggest that the procedure is safe and effective.


  • Comparison of complication rates for unilateral and bilateral percutaneous nephrolithotomy (PCNL) using a modified Clavien grading system

    by Adam O. Kadlec, Kristin A. Greco, Zachary C. Fridirici, Spencer T. Hart, Ted G. Vellos, Thomas M. Turk

    What's known on the subject? and What does the study add? Standardised complication reporting for urological procedures has been encouraged. Percutaneous nephrolithotomy (PCNL) has an acceptably low complication rate, with high‐grade complications being rare. A recent review shows that complication rates for PCNL vary from 15% to 60%, but the Clavien system has not been used in all studies. Also, no study has directly compared unilateral and bilateral procedures. In a direct comparison retrospective study, we showed that bilateral procedures had a higher overall complication rate and suggest that this is probably due to an increased number of percutaneous tracts. OBJECTIVE: To compare complication rates of unilateral vs bilateral percutaneous nephrolithotomy (PCNL) using the modified Clavien grading system. PATIENTS AND METHODS: Single‐institution retrospective chart review. Identified patients who had synchronous bilateral PCNL (B‐PCNL) over an 11‐year period (2000–2011). B‐PCNL patients were matched by age, gender, and stone burden per renal unit with patients who underwent unilateral PCNL (U‐PCNL) over the same period. Complications were recorded and classified using the modified Clavien classification system, and then compared with a two‐sided chi‐square test of proportions. RESULTS: In all, 47 B‐PCNL patients [mean (range) age 54 (14–84) years] and 78 U‐PCNL patients [mean (range) age 54 (17–91 years] were compared. The mean (range) stone burden per renal unit was 2.8 (0.7–7.0) cm and 2.9 (0.7–9.0) cm, respectively. The overall complication rate was higher for B‐PCNL (53.2% vs 30.8%, P = 0.013). Rates of Grade I and Grade II complications trended toward being higher in the B‐PCNL group. Low‐grade complications (Grade I and II combined) occurred more often in the B‐PCNL group ( P = 0.011); the most common low‐grade complication was fever. Two procedures terminated for poor visualisation due to bleeding were successfully completed in delayed fashion with no transfusion and were classified as Grade I complications. There were equivalently low rates of Grade III complications. There were no Grade IV or V complications. CONCLUSIONS: B‐PCNL carries a higher overall complication rate than U‐PCNL when the modified Clavien system is used for classification. Patients undergoing U‐PCNL who have more than one tract dilatation have a higher complication rate than those who have only one tract dilatation. High‐grade complications are uncommon for both procedures.


  • Metabolic Syndrome and Urinary Stone Composition: What Factors Matter Most?

    by Adam O. Kadlec, Kristin Greco, Zachary C. Fridirici, Spencer T. Hart, Ted Vellos, Thomas M. Turk


  • Effect of Renal Function on Urinary Mineral Excretion and Stone Composition

    by Adam O. Kadlec, Kristin A. Greco, Zachary C. Fridirici, Daniel Gerber, Thomas M.T. Turk